| 2026-04-14 | +68.1% | legal | MT Newswires | Sector Update: Health Care Stocks Higher Late Afternoon |
| 2026-04-14 | +68.1% | legal | MT Newswires | Sector Update: Health Care Stocks Rise Tuesday Afternoon |
| 2026-04-14 | +68.1% | news | MT Newswires | Top Midday Gainers |
| 2026-04-14 | +68.1% | news | Barrons.com | This Healthcare Stock Is Rising 69%. It’s Getting Bought Out for a Big Premium. |
| 2026-04-14 | +68.1% | M&A | Seeking Alpha | Avanos Medical rockets 67% on $1.27B acquisition by American Industrial Partners |
| 2026-04-14 | +68.1% | legal | SEC EDGAR | AVNS 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-04-14 | +68.1% | M&A | PR Newswire | Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion - PR Newswire |
| 2026-04-14 | +68.1% | news | ChartMill | AVNS Stock Alert: Halper Sadeh LLC is Investigating Whether Avanos Medical, Inc. is Obtaining a Fair Price for its Shareholders - ChartMill |
| 2026-04-14 | +68.1% | M&A | Reuters | AIP to take Avanos Medical private in $1.27 billion deal - Reuters |
| 2026-04-14 | +68.1% | news | marketscreener.com | AVNS Stock Alert: Halper Sadeh LLC is Investigating Whether Avanos Medical, Inc. is Obtaining a Fair Price for its Shareholders - marketscreener.com |
| 2026-04-14 | +68.1% | news | Stock Titan | AIP to take Avanos (NYSE: AVNS) private at $25 per share - Stock Titan |
| 2026-04-14 | +68.1% | news | Benzinga | Why Is Avanos Medical Stock Skyrocketing Tuesday? - Avanos Medical (NYSE:AVNS) - Benzinga |
| 2026-04-14 | +68.1% | news | Benzinga | Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday - Benzinga |
| 2026-04-14 | +68.1% | news | Benzinga | 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga |
| 2023-05-03 | -17.3% | legal | SEC EDGAR | AVNS 8-K: 2.02, 5.07 (SEC Filing) |
| 2024-01-04 | -17.0% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2022-02-23 | +15.4% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2024-10-30 | -15.2% | legal | SEC EDGAR | AVNS 8-K: 2.02, 5.02 (SEC Filing) |
| 2023-11-01 | +14.2% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2021-08-03 | -12.1% | legal | SEC EDGAR | AVNS 8-K: 2.02, 5.02 (SEC Filing) |
| 2021-11-02 | +11.8% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2026-02-23 | -11.5% | earnings | Seeking Alpha | Avanos Medical Q4 2025 Earnings Preview |
| 2026-01-14 | +8.5% | news | Seeking Alpha | Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2026-01-14 | +8.5% | news | Seeking Alpha | Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2025-08-05 | -8.4% | earnings | Seeking Alpha | Avanos maintains $665M–$685M revenue target amid HA divestiture and tariff impact |
| 2025-08-05 | -8.4% | earnings | Seeking Alpha | Avanos Medical, Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-08-05 | -8.4% | earnings | Seeking Alpha | Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript |
| 2025-08-05 | -8.4% | earnings | Seeking Alpha | Avanos Medical Non-GAAP EPS of $0.17 beats by $0.02, revenue of $175M beats by $9.5M |
| 2025-08-05 | -8.4% | legal | SEC EDGAR | AVNS 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2021-05-07 | -7.9% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2021-12-13 | +7.7% | legal | SEC EDGAR | AVNS 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-02-24 | -7.3% | news | Seeking Alpha | Avanos expects $700M–$720M sales in 2026 as China exit drives tariff mitigation |
| 2026-02-24 | -7.3% | earnings | Seeking Alpha | Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript |
| 2026-02-24 | -7.3% | earnings | Seeking Alpha | Avanos Medical, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-24 | -7.3% | earnings | Seeking Alpha | Avanos Medical Non-GAAP EPS of $0.29, revenue of $180.9M |
| 2026-02-24 | -7.3% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2026-02-24 | -7.3% | earnings | Investing.com | Earnings call transcript: Avanos Medical Q4 2025 beats forecasts but stock dips - Investing.com |
| 2022-05-17 | +7.0% | legal | SEC EDGAR | AVNS 8-K: 8.01 and (SEC Filing) |
| 2022-01-21 | +6.0% | legal | SEC EDGAR | AVNS 8-K: 2.01, 2.03 (SEC Filing) |
| 2024-11-05 | +5.3% | news | Seeking Alpha | Avanos Medical announces share buyback |
| 2024-11-04 | +4.7% | legal | SEC EDGAR | AVNS 8-K: 8.01 and (SEC Filing) |
| 2026-02-03 | +4.5% | news | Stock Titan | Medicare to pay up to $2,008.72 for Avanos non-opioid pain devices - Stock Titan |
| 2023-03-06 | -4.3% | legal | SEC EDGAR | AVNS 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-12 | +4.2% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2026-01-29 | +4.2% | news | Yahoo Finance | Reasons to Retain Avanos Medical Stock in Your Portfolio Now - Yahoo Finance |
| 2022-10-11 | -4.1% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2026-03-11 | +4.1% | news | Seeking Alpha | Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript |
| 2025-11-04 | -4.0% | earnings | Seeking Alpha | Avanos Medical Q3 2025 Earnings Preview |
| 2025-07-31 | -3.9% | M&A | Seeking Alpha | Avanos announces divestiture of Hyaluronic Acid product line to Channel-Markers Medical |
| 2023-01-11 | +3.8% | legal | SEC EDGAR | AVNS 8-K: 2.05, 5.02, 7.01 (SEC Filing) |
| 2025-04-30 | -3.7% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2025-05-06 | +3.6% | earnings | Seeking Alpha | Avanos Medical, Inc. 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-06 | +3.6% | earnings | Seeking Alpha | Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript |
| 2025-05-06 | +3.6% | earnings | Seeking Alpha | Avanos Medical Non-GAAP EPS of $0.26, revenue of $167.5M |
| 2025-05-06 | +3.6% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2025-05-06 | +3.6% | earnings | Seeking Alpha | Avanos Medical, Inc. 2025 Q1 - Results - Earnings Call Presentation (NYSE:AVNS) 2025-05-06 - Seeking Alpha |
| 2022-11-02 | +3.4% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2024-07-31 | +3.3% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2024-12-03 | -3.2% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2024-07-01 | -3.0% | legal | SEC EDGAR | AVNS 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-08-09 | -3.0% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2024-05-02 | +2.6% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2025-04-17 | +2.4% | news | Seeking Alpha | Avanos Medical: Cheap, But With Caveats |
| 2026-04-06 | -2.4% | news | Cổng thông tin điện tử Tỉnh Sơn La | Will Avanos (AVNS) Stock Grow in 2026 | Price at $13.84, Down 0.79% - Trader Community Insights - Cổng thông tin điện tử Tỉnh Sơn La |
| 2024-11-11 | -2.3% | legal | Stock Titan | Avanos Medical Secures Medicare Coverage for Non-Opioid Pain Pumps Under NOPAIN Act - Stock Titan |
| 2025-04-28 | +2.2% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2026-04-10 | +2.2% | legal | Stock Titan | AVNS SEC Filings - Avanos Medical 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2024-02-20 | +2.1% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2025-08-29 | +2.1% | news | Seeking Alpha | The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice |
| 2025-08-29 | +2.1% | news | Seeking Alpha | The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice (NYSE:AVNS) - Seeking Alpha |
| 2026-04-16 | -1.9% | news | Exec Edge | Nanox Continues Expanding Nanox.ARC in U.S. & Israel |
| 2026-04-16 | -1.9% | executive | Stock Titan | Avanos (NYSE: AVNS) CEO surrenders 21,194 shares to cover RSU taxes - Stock Titan |
| 2022-06-30 | +1.8% | legal | SEC EDGAR | AVNS 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2025-10-23 | -1.8% | M&A | Seeking Alpha | WRS Group to acquire Avanos Medical's US Game Readyorthopedic rental business |
| 2025-10-23 | -1.8% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2025-03-17 | +1.5% | executive | Seeking Alpha | Avanos Medical appoints David Pacitti as chief executive officer |
| 2025-03-17 | +1.5% | legal | SEC EDGAR | AVNS 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-05-04 | +1.5% | legal | SEC EDGAR | AVNS 8-K: 2.02, 5.02, 5.07 (SEC Filing) |
| 2023-08-09 | -1.5% | legal | SEC EDGAR | AVNS 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-03-26 | +1.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2023-06-08 | -1.4% | legal | SEC EDGAR | AVNS 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-04-01 | -1.3% | news | Stock Titan | [Form 4/A] AVANOS MEDICAL, INC. Amended Insider Trading Activity - Stock Titan |
| 2026-04-01 | -1.3% | executive | Stock Titan | CFO at Avanos (NYSE: AVNS) awarded new stock options and RSUs - Stock Titan |
| 2026-04-01 | -1.3% | news | Stock Titan | Avanos Medical (NYSE: AVNS) SVP receives new stock options and RSU awards - Stock Titan |
| 2026-04-01 | -1.3% | news | Stock Titan | Avanos (NYSE: AVNS) grants options and TRSUs to SVP Delgado - Stock Titan |
| 2026-04-01 | -1.3% | executive | Stock Titan | Avanos (NYSE: AVNS) CEO Pacitti receives new option and RSU grants - Stock Titan |
| 2026-04-01 | -1.3% | executive | Stock Titan | Avanos (NYSE: AVNS) CFO granted 70,115 options and 29,481 TRSUs - Stock Titan |
| 2026-04-01 | -1.3% | news | AD HOC NEWS | Avanos Medical Inc Stock: Institutional Confidence Builds Amid Pain Management and Acute Care Focus - AD HOC NEWS |
| 2023-02-17 | -1.2% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2021-12-15 | -1.2% | legal | SEC EDGAR | AVNS 8-K: 8.01 and (SEC Filing) |
| 2026-03-19 | -1.1% | news | Yahoo Finance | Reasons to Retain Avanos Medical Stock in Your Portfolio for Now - Yahoo Finance |
| 2025-12-05 | +1.1% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2026-04-17 | -1.1% | news | DirectorsTalk Interviews | Avanos Medical, Inc. (AVNS) Stock Analysis: Riding the Wave with a 52-Week High and Strategic Growth in Medical Devices - DirectorsTalk Interviews |
| 2026-04-17 | -1.1% | earnings | Benzinga | Top 2 Health Care Stocks That May Fall Off A Cliff In Q2 - Benzinga |
| 2023-06-20 | +1.1% | legal | SEC EDGAR | AVNS 8-K: 7.01, 8.01 (SEC Filing) |
| 2022-05-25 | -1.0% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2026-04-20 | +0.9% | earnings | UBND thành phố Hải Phòng | Avanos (AVNS) Stock: Changing Trend? (Dormant) 2026-04-20 - Profit Surge - UBND thành phố Hải Phòng |
| 2026-04-15 | -0.9% | M&A | Zacks | Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium |
| 2026-04-15 | -0.9% | M&A | Medical Device Network | AIP to acquire Avanos Medical for $1.27bn |
| 2026-04-15 | -0.9% | M&A | MedTech Dive | AIP to acquire Avanos Medical in $1.27B go-private deal |
| 2026-04-15 | -0.9% | news | Seeking Alpha | Avanos Medical Stock Looks Capped After American Industrial Partners' Offer |
| 2026-04-15 | -0.9% | news | Seeking Alpha | Avanos Medical Stock Looks Capped After American Industrial Partners' Offer (NYSE:AVNS) - Seeking Alpha |
| 2023-10-02 | +0.8% | legal | SEC EDGAR | AVNS 8-K: 2.01 and (SEC Filing) |
| 2026-02-26 | -0.8% | legal | SEC EDGAR | AVNS 8-K: 1.01, 8.01 (SEC Filing) |
| 2025-02-26 | -0.7% | earnings | Seeking Alpha | Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript |
| 2025-02-26 | -0.7% | earnings | Seeking Alpha | Avanos Medical Non-GAAP EPS of $0.43 beats by $0.03, revenue of $179.6M beats by $2.37M |
| 2025-02-26 | -0.7% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2025-09-23 | +0.6% | news | TradingView | ETFs Investing in Avanos Medical, Inc. Stocks - TradingView |
| 2023-02-21 | -0.6% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2025-04-25 | +0.6% | news | Stock Titan | AVNS Stock Price, News & Analysis - Stock Titan |
| 2021-07-09 | -0.6% | legal | SEC EDGAR | AVNS 8-K: 1.01 and (SEC Filing) |
| 2021-10-05 | -0.5% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2025-04-18 | -0.4% | legal | SEC EDGAR | AVNS 8-K: 5.02 and (SEC Filing) |
| 2025-04-18 | -0.4% | legal | SEC EDGAR | AVNS 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-04-18 | -0.4% | news | Intellectia AI | AVNS Forecast — Price Prediction for 2026. Should I Buy AVNS? - Intellectia AI |
| 2025-02-25 | +0.4% | earnings | Seeking Alpha | Avanos Medical Q4 2024 Earnings Preview |
| 2026-04-23 | -0.3% | news | Exec Edge | Nanox To Deploy 300 Nanox.ARC Systems in The U.S. Over 3 Years |
| 2025-11-05 | -0.3% | earnings | Seeking Alpha | Avanos Medical, Inc. (AVNS) Q3 2025 Earnings Call Transcript |
| 2025-11-05 | -0.3% | earnings | Seeking Alpha | Avanos Medical, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-05 | -0.3% | earnings | Seeking Alpha | Avanos Medical Non-GAAP EPS of $0.22 beats by $0.10, revenue of $177.8M beats by $13.3M |
| 2025-11-05 | -0.3% | legal | SEC EDGAR | AVNS 8-K: 2.02 and (SEC Filing) |
| 2025-11-05 | -0.3% | earnings | Yahoo Finance | Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance |
| 2023-08-01 | -0.3% | legal | SEC EDGAR | AVNS 8-K: 8.01 and (SEC Filing) |
| 2026-04-19 | +0.3% | news | Simply Wall St. | Is It Too Late To Consider Buying Avanos Medical (AVNS) After Its Recent Share Price Surge? |
| 2025-09-18 | -0.3% | news | Yahoo Finance | Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio - Yahoo Finance |
| 2026-01-23 | -0.1% | legal | DirectorsTalk Interviews | Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Growth Potential Amidst Valuation Challenges in the Medical Device Sector - DirectorsTalk Interviews |
| 2026-02-12 | +0.0% | news | simplywall.st | Avanos Medical, Inc. (NYSE:AVNS) Held Back By Insufficient Growth Even After Shares Climb 26% - simplywall.st |
| 2026-04-24 | — | news | Stock Titan | Avanos Medical (NYSE: AVNS) SVP has shares withheld to cover RSU taxes - Stock Titan |
| 2026-04-24 | — | executive | Stock Titan | AVANOS MEDICAL (AVNS) CFO surrenders shares for taxes on RSU vesting - Stock Titan |